Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP345625.RAO4742cz4pbDIMUvbR1gWKpzFMvMOzrq4eP3IyjMExcM130_assertion description "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345625.RAO4742cz4pbDIMUvbR1gWKpzFMvMOzrq4eP3IyjMExcM130_provenance.
• NP284430.RA8RaIA5cuCfS6W4NMkMQuhH0LGSScWkYPQBrZN6YU7yY130_assertion description "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284430.RA8RaIA5cuCfS6W4NMkMQuhH0LGSScWkYPQBrZN6YU7yY130_provenance.
• NP284428.RAYfaQLTGgf4ZV91zYPq6xgs-fwaTm4Kwz7QjSiMWfX_U130_assertion description "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284428.RAYfaQLTGgf4ZV91zYPq6xgs-fwaTm4Kwz7QjSiMWfX_U130_provenance.
• NP284429.RASRmZh9hU2pSMEkcDWv-F7qMO_7a_cd4rsBWqLleB4DM130_assertion description "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284429.RASRmZh9hU2pSMEkcDWv-F7qMO_7a_cd4rsBWqLleB4DM130_provenance.
• assertion description "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP754111.RAsB5mCXyIZQyw7Dolof2rRsKUdQuKYAXPseYuXgaFY9M130_assertion description "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754111.RAsB5mCXyIZQyw7Dolof2rRsKUdQuKYAXPseYuXgaFY9M130_provenance.
• NP986227.RAOHU4fIxXjWNtmlf3Qk2Pzql1ke7oKbFbBxmkkE6zCxU130_assertion description "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986227.RAOHU4fIxXjWNtmlf3Qk2Pzql1ke7oKbFbBxmkkE6zCxU130_provenance.
• assertion description "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP594911.RAl6qrnCfe674VPcDx2dK5rzYIb_VDpYM0Jg6fV74S-2A130_assertion description "[Double-labeling studies demonstrated that the low levels of cerebrovascular NOS-III were associated with increased levels of the pro-apoptosis gene product, p53 in smooth muscle and endothelial cells, suggesting a role for altered NOS-III expression in AD-associated vascular degeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594911.RAl6qrnCfe674VPcDx2dK5rzYIb_VDpYM0Jg6fV74S-2A130_provenance.